Clinical trial
Screening for Edema and Breast Cancer-Related Lymphedema in Patients Undergoing Targeted Therapy for Breast Cancer
NCT05142800 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Screening for Edema and Breast Cancer-Related Lymphedema in Patients Undergoing Targeted Therapy for Breast Cancer
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 13, 2018
- Completion date
- September 30, 2026
- Enrollment
- 261 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer, breast cancer lymphedema, breast cancer metastatic, breast cancer stage, edema, edema arm, lymphedema, lymphedema arm, lymphedema of the hands, lymphedema of upper arm, lymphedema of upper limb